Dual therapy with lopinavir/ritonavir plus lamivudine could be a viable alternative for antiretroviral-therapy-naive adults with HIV-1 infection regardless of HIV viral load or subgenotype in resource-limited settings: A randomised, open-label and non-inferiority study from China
Indian J Med Microbiol
; 2018 Dec; 36(4): 513-516
Article
| IMSEAR
| ID: sea-198835
Texte intégral:
1
Indice:
IMSEAR
Type d'étude:
Clinical_trials
Texte intégral:
Indian J Med Microbiol
Thème du journal:
Microbiology
Année:
2018
Type:
Article